title: Determination of the anthrapyrazole anticancer drug CI-941 in plasma and urine by solid-phase extraction and high-performance liquid chromatography.
authors: Drug Development Section, Institute of Cancer Research, Sutton, Surrey, U.K.
authors: M A
authors: MA
authors: Graham
authors: D R
authors: DR
authors: Newell
authors: A H
authors: AH
authors: Calvert
mesh_terms: D000880:Anthraquinones / Q000097:blood / Q000378:metabolism* / Q000652:urine; D000970:Antineoplastic Agents / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D011720:Pyrazoles / Q000097:blood / Q000378:metabolism* / Q000652:urine; D047069:Pyrazolones; D013057:Spectrum Analysis
chemical_list: D000880:Anthraquinones; D000970:Antineoplastic Agents; D011720:Pyrazoles; D047069:Pyrazolones; C050637:losoxantrone